Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NRGene

NRGene
2009 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Seed LATEST DEAL TYPE
Description

Developer of of software-based genetic tools. The company specializes in the development of advanced computational tools and algorithmic models to facilitate trait discovery and selection for seed companies, animal breeders and academia.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Software
Primary Office
  • Golda Meir Street 3
  • Ness Ziona
  • Israel

+972 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NRGene’s full profile, request a free trial.

NRGene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Feb-2012 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NRGene Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OnRamp BioInformatics Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
00000000000000 Corporate Backed or Acquired Bangalore, India 00.000 000000000 00.000
00000000 Venture Capital-Backed Mountain View, CA 00 00000 00000000000 00000
00000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00.000 000000000000 00.000
0000000 Venture Capital-Backed Rijswijk, Netherlands 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

NRGene Executive Team (5)

Name Title Board
Seat
Contact
Info
Gil Ronen Ph.D Co-Founder & Chief Executive Officer
Dorit Kreiner Chief Financial Officer
Guy Kol Co-Founder & Senior Vice President, Product & Strategic Alliances
David Lieber Co-Founder & Chairman
Omer Barad Ph.D Vice President, Research & Development

NRGene Board Members (1)

Name Representing Role Since Contact
Info
David Lieber NRGene Co-Founder & Chairman 000 0000